| Financial Year |
March 31 2023 |
| Monetary Funds |
669,402,576.04 |
| Held-for-trading Financial Assets |
91,547,671.23 |
| Notes Receivable |
-- |
| Accounts Receivable |
817,004,790.88 |
| Advances to Suppliers |
43,153,612.93 |
| Other Receivables |
77,020,073.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
953,244,704.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
180,725,990.33 |
| Other Current Assets |
28,956,172.63 |
| Total Current Assets |
2,889,463,418.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
185,459,678.52 |
| Long-term Equity Investment |
341,148,702.06 |
| Investment Properties |
-- |
| Fixed Assetes |
938,233,469.52 |
| Under-construction Projects |
3,929,449.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
177,636,987.94 |
| R&D expenses |
-- |
| Goodwill |
165,387.49 |
| Long-Term Deferred and Prepaid Expenses |
19,472,666.08 |
| Deferred Income Tax Assets |
66,019,317.88 |
| Other Non-Current Assets |
2,181,106.19 |
| Sub-Total of Non-Current Assets |
1,765,491,874.83 |
| Total Assets |
4,654,955,293.46 |
| Short-Term Loans |
545,791,340.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
391,655,181.37 |
| Accounts Payable |
534,680,420.74 |
| Accounts Received In Advance |
2,421,122.70 |
| Employee Compensation Payable |
25,152,815.28 |
| Taxes Payable |
83,494,388.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
37,459,553.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,666,365.72 |
| Other Current Liabilities |
46,698,652.52 |
| Sub-Total of Current Liabilities |
1,888,335,108.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,408,151.40 |
| Deferred Income Tax Liabilities |
6,693,261.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,721,544.89 |
| Total Liabilities |
1,908,056,653.48 |
| Paid-In Capital(Or Share Stock) |
780,541,776.00 |
| Capital Surplus |
1,874,811,445.26 |
| Surplus Reserve |
251,000,675.74 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-153,526,070.63 |
| Minority Stockholder's Interest |
-42,200,129.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,789,098,769.60 |
| Owner's Equity（Stockholder's Equity） |
2,746,898,639.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,654,955,293.46 |
